Department of Cerebrovascular Disease, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
Department of Cerebrovascular Disease, General Medical College of Guilin Medical College, Guilin, China.
Bioengineered. 2022 Mar;13(3):7340-7350. doi: 10.1080/21655979.2022.2037373.
The objective of the research was to investigate action mechanism of oxidative stress and cerebral injuries after subarachnoid hemorrhage (SAH) by Ghrelin and angiogenic factor G-patch and FHA domain 1 (Aggf1) and offer new research ideas to SAH clinical treatment and SAH-induced early cerebral injuries. SAH rat models were prepared by prechiasmatic anterior cistern injection. Specific Ghrelin and Aggf1 small interfering ribonucleic acid (siRNA) were designed and injected into silence Ghrelin or Aggf1 in rat left lateral ventricles. Rats were divided randomly into sham-operated (sham), SAH model, negative control siRNA, Ghrelin silence (Ghrelin), and Aggf1 silence groups. Changes of rat neurological impairment, encephaledema, cerebral tissue phosphorylated protein kinase (p-Akt), and content changes of caspase-3 protein and oxidative stress indexes were observed, including glutathione (GSH) and oxidized glutathione (GSSG). Results showed scores of neurological impairment and water content in SAH model group were reduced compared with sham group, while p-Akt protein and GSH contents were enhanced. However, caspase-3 protein and GSSG contents were declined, showing statistically meaningful difference ( < 0.05). Compared with SAH model group, scores of neurological impairment, cerebral tissue water content, and caspase-3 protein and GSSG contents in silence Ghrelin and Aggf1 groups were increased, while p-Akt protein and GSH contents were decreased, demonstrating statistically meaningful difference ( < 0.05). To conclude, silence Ghrelin and Aggf1 aggravated early cerebral injuries after SAH, revealing that Ghrelin and Aggf1 could protect brains to some degree.
本研究旨在通过 Ghrelin 和血管生成因子 G 补丁和 FHA 域 1(Aggf1)探讨氧化应激和蛛网膜下腔出血(SAH)后脑损伤的作用机制,为 SAH 的临床治疗和 SAH 诱导的早期脑损伤提供新的研究思路。通过前视交叉前池注射制备 SAH 大鼠模型。设计了特异性 Ghrelin 和 Aggf1 小干扰核糖核酸(siRNA),并将其注入大鼠左侧脑室以沉默 Ghrelin 或 Aggf1。大鼠随机分为假手术(sham)、SAH 模型、阴性对照 siRNA、Ghrelin 沉默(Ghrelin)和 Aggf1 沉默组。观察大鼠神经功能缺损、脑水肿、脑组织磷酸化蛋白激酶(p-Akt)、半胱天冬酶-3 蛋白含量变化和氧化应激指标,包括谷胱甘肽(GSH)和氧化型谷胱甘肽(GSSG)。结果显示,与 sham 组相比,SAH 模型组大鼠神经功能缺损评分和脑组织含水量降低,p-Akt 蛋白和 GSH 含量升高,而 caspase-3 蛋白和 GSSG 含量降低,差异有统计学意义( < 0.05)。与 SAH 模型组相比,沉默 Ghrelin 和 Aggf1 组大鼠神经功能缺损评分、脑组织含水量和 caspase-3 蛋白及 GSSG 含量升高,p-Akt 蛋白和 GSH 含量降低,差异有统计学意义( < 0.05)。综上所述,沉默 Ghrelin 和 Aggf1 加重了 SAH 后的早期脑损伤,表明 Ghrelin 和 Aggf1 对脑有一定的保护作用。